Check Point Software Technologies Ltd.
—- Market cap
- —
- Debt
- +$4.83B
- Cash
- −$1.80B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap
Decision snapshot: CHKP stock price vs HRMY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HRMY's multiple
Needs EPS (TTM).
Implied fair value · at CHKP's multiple
Needs CHKP P/E.
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CHKP FY 2025 (ended Dec 31, 2025) · HRMY FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 94% equity / 6% debt · EV / Revenue 2.13x · EV / EBITDA 7.27x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CHECK POINT SOFTWARE TECHNOLOGIES LTD. · implied price per share
The ordinary-share to listed-security ratio could not be verified.
HARMONY BIOSCIENCES HOLDINGS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.68x
0.19x
Net debt / EBITDA
Leverage against operating earnings
2.99x
-2.41x
Cash and equivalents
Liquid reserves on the balance sheet
$1.80B
$775.34M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Palo Alto Networks Inc
CHKP vs PANW
Fortinet, Inc.
CHKP vs FTNT
Zscaler, Inc.
CHKP vs ZS
CrowdStrike Holdings, Inc.
CHKP vs CRWD
Jazz Pharmaceuticals plc
CHKP vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
CHKP vs SUPN
Intra-Cellular Therapies, Inc.
CHKP vs ITCI
ACADIA PHARMACEUTICALS INC
CHKP vs ACAD
Vanda Pharmaceuticals Inc.
CHKP vs VNDA
LivaNova PLC
CHKP vs LIVN
$4.83B
$163.66M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.